T1	Intervention 0 37	Acute intravenous L-arginine infusion
T2	Intervention 48 101	endothelin-1 levels and improves endothelial function
T3	Intervention 119 167	angina pectoris and normal coronary arteriograms
T4	Intervention 186 213	asymmetric dimethylarginine
T5	Intervention 248 305	hypothesis that asymmetric dimethylarginine (ADMA) levels
T6	Intervention 338 367	endothelin-1 and nitric oxide
T7	Intervention 404 429	cardiac syndrome X (CSX).
T8	Intervention 491 501	L-arginine
T9	Intervention 516 536	endothelial function
T10	Intervention 464 487	an intravenous infusion
T11	Intervention 658 692	L-arginine (0.125 g/min) or saline
T12	Intervention 595 598	CSX
T13	Intervention 730 801	L-arginine or saline infusions, an intravenous insulin bolus (0.1 U/kg)
T14	Intervention 818 834	euglycemic clamp
T15	Intervention 856 884	ADMA and endothelin-1 levels
T16	Intervention 992 1099	saline, L-arginine infusion increased basal forearm blood flow, nitrite and nitrate (NOx), and forearm cGMP
T17	Intervention 1142 1223	insulin bolus, during saline, insulin-induced NOx, endothelin-1, and forearm cGMP
T18	Intervention 1266 1276	L-arginine
T19	Intervention 1313 1328	all endothelial
T20	Intervention 1406 1442	saline infusion, L-arginine infusion
T21	Intervention 1473 1477	ADMA
T22	Intervention 1517 1542	basal endothelin-1 levels
T23	Intervention 1574 1640	insulin-induced incremental levels of NOx and forearm cGMP release
T24	Intervention 1654 1665	Plasma ADMA
T25	Intervention 1704 1707	CSX
T26	Intervention 1751 1763	endothelin-1
T27	Intervention 1812 1831	plasma NOx and cGMP
T28	Intervention 1862 1885	intravenous L-arginine.
T29	Intervention 2014 2018	CSX.
T30	Intervention 1920 1924	ADMA
